Heart Week: Cardiac Screening and Monitoring in Clinical Practice

Cardiac monitoring and ECG are essential components of cardiovascular care across Australian healthcare settings. Across primary care, acute care, and community settings, structured cardiovascular assessment supports early detection of disease, risk stratification, and continuity of care. This article outlines the clinical importance of evidence-based cardiac diagnostics during Heart Week and beyond.

Cardiovascular disease (CVD) remains a major contributor to morbidity and mortality in Australia. According to the Australian Institute of Health and Welfare (AIHW), CVD was the underlying cause of 24% of all deaths nationally in 2022, highlighting its ongoing public health impact.¹

While Heart Week encourages community awareness, these clinical processes remain embedded in routine healthcare practice. For healthcare professionals, structured cardiovascular assessment supports early risk identification, timely intervention, and continuity of care across the patient journey.

The Role of Cardiac Screening in Risk Identification

In clinical practice, cardiac screening refers to structured assessment of cardiovascular risk using tools such as blood pressure measurement, ECG, and risk profiling in primary care and acute care settings.

Cardiac screening plays a central role in identifying both symptomatic and asymptomatic cardiovascular risk factors. In primary care, assessment commonly includes:

• Blood pressure measurement
  • Cardiovascular risk profiling
  • Electrocardiography (ECG), where clinically indicated
  • Review of comorbidities such as diabetes and dyslipidaemia

National data indicates that around one in three Australian adults have high blood pressure, a major risk factor for cardiovascular disease, and many may be unaware of their condition or have uncontrolled readings.² ³

Routine cardiovascular assessment allows clinicians to:

• Stratify patient risk
  • Initiate preventative management strategies
  • Identify arrhythmias or conduction abnormalities
  • Support referral pathways where required

Heart Week reinforces the importance of these structured assessments, particularly in high-risk populations.

ECG in Primary Care and Outpatient Assessment

Electrocardiography (ECG) remains a foundational tool in cardiac screening and diagnostic evaluation. In general practice and outpatient clinics, ECG may be used to:

• Investigate chest pain or palpitations
  • Assess syncope or dizziness
  • Monitor known cardiac conditions
  • Establish baseline cardiac function prior to procedures

Accurate ECG recording and interpretation are critical to avoid misdiagnosis or delayed escalation of care. High signal quality, appropriate lead placement, and reliable data capture can contribute to clinical confidence and workflow efficiency.

CARDIOVIT FT-1

Cardiac Monitoring in Acute and Critical Care

In hospital and emergency environments, cardiac monitoring extends beyond intermittent assessment to continuous surveillance.

Cardiac monitoring systems support clinicians in:

• Detecting acute arrhythmias
  • Monitoring haemodynamic stability
  • Guiding pharmacological intervention
  • Supporting advanced life support protocols

In critical care, cardiac output monitoring and advanced haemodynamic assessment may be required to guide fluid management and vasoactive therapy decisions. Reliable, real-time data availability directly influences patient safety and clinical outcomes.

Cardiovascular Assessment Across the Care Continuum

Cardiac diagnostics are utilised across Australian healthcare environments, each with distinct clinical priorities.

Primary Care

• Preventative screening
• Chronic disease management
• Cardiovascular risk assessment

Acute Care

• Continuous monitoring
• Emergency response
• Stabilisation and intervention

Community and Regional Settings

• Portable assessment tools enabling access to cardiac evaluation outside hospitals

Ensuring accessibility and consistency of cardiovascular assessment tools across care settings supports continuity and informed decision-making.

SCHILLER Portable Assessment Tools

Supporting Cardiac Screening with Established Diagnostic Solutions

As part of our commitment to supporting cardiovascular care, InterMed partners with global manufacturer SCHILLER to provide cardiopulmonary diagnostic, monitoring, and resuscitation systems used across Australian healthcare settings.

SCHILLER’s portfolio supports:

• Resting and exercise ECG assessment
• Cardiopulmonary diagnostics
• Defibrillation and emergency response
• Integrated patient monitoring
• Medical software solutions that facilitate data review and workflow integration

FRED easy G2

Clinical application across care settings:

• Primary care: Reliable ECG acquisition supports early detection, risk stratification, and preventative management.
  • Acute and critical care: Continuous cardiac monitoring and defibrillation systems assist clinicians in responding rapidly to deteriorating patients and support advanced life support protocols.
  • Regional and community settings: Portable cardiac diagnostic platforms enable access to cardiovascular assessment outside metropolitan hospitals, supporting continuity of care in rural and remote areas.

InterMed’s role extends beyond supply. We provide product education, local service support, and technical guidance to help healthcare teams integrate cardiac diagnostic technologies safely and effectively within their workflows.

Learn more about SCHILLER’s 50 years of innovation in cardiac diagnostics.

By aligning clinically validated diagnostic systems with local expertise and support, healthcare providers maintain accuracy, consistency, and continuity of care across cardiovascular pathways.

For a detailed overview of SCHILLER’s diagnostic solutions available in Australia, see our Medical Diagnostic Equipment Solutions feature.

Cardiac Diagnostics Beyond Awareness Campaigns

While Heart Week highlights cardiovascular health, cardiac screening and cardiac monitoring remain year-round clinical priorities.

Early identification of cardiovascular risk, timely monitoring of disease progression, and reliable assessment during acute events are fundamental to improving patient outcomes.

By supporting access to accurate and dependable cardiac diagnostic solutions, healthcare providers can place informed assessment at the centre of heart health management across all care environments.

References

1. Australian Institute of Health and Welfare (AIHW). Heart, stroke and vascular disease – Australian facts. AIHW, Canberra. Latest available national data. Available at: https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts/contents/disease-types
2. Australian Institute of Health and Welfare (AIHW) / Australian Bureau of Statistics (ABS). High blood pressure in Australian adults: National Health Survey 2017–18 (latest measured data). Available at: https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts/contents/risk-factors/high-blood-pressure
3. National Hypertension Taskforce. Roadmap for Blood Pressure Awareness & Control. Available at: https://www.hypertensiontaskforce.au/roadmap/

Disclaimer:

Some of the products mentioned are intended for use by healthcare professionals only. Always read the label and follow the directions for use.

______________________________________________________________________________________________

FAQs: Cardiac Screening in Clinical Practice

Q: What is cardiac screening in primary care?

A: Cardiac screening refers to structured assessment of cardiovascular risk factors, including blood pressure monitoring, risk profiling, and ECG where clinically indicated.

Q: Why is ECG important for early detection of cardiovascular disease?

A: ECG assists in identifying arrhythmias, conduction abnormalities, and other cardiac irregularities that may not be clinically apparent during routine examination.

Q: How is cardiac monitoring used in hospitals?

A: In acute and critical care settings, continuous cardiac monitoring supports real-time assessment of rhythm and haemodynamic stability, guiding urgent clinical decision-making.

Q: What SCHILLER solutions are commonly used in Australian healthcare settings?

A: SCHILLER provides a range of cardiopulmonary diagnostic systems, monitoring platforms, defibrillators, and medical software solutions to support patient care across primary care, acute care, and community settings.

Q: How does InterMed support clinicians using SCHILLER equipment?

A: InterMed provides education, local service support, and technical guidance to help healthcare teams integrate SCHILLER cardiac diagnostic technologies safely and effectively within existing workflows.